We found that 101 genes (126 probes) showed a pattern of differential expression in lung cancer clinical samples that significantly correlated with the expression change noted in A549 cells following depletion of NME2; 44 genes were upregulated and 57 genes downregulated in advanced compared to early stages (Figure 3C). The gene discussed is NME2; the disease is lung carcinoma.